Diversity of Physicians’ Handwriting and Name Stamp in Chemotherapy Prescriptions: Potential Target for Fraud
Abstract
Backgrounds: Verification and authentication of the paper-based handwritten prescriptions is of great importance for antineoplastic medications that are good targets for forgery and fraud. Pharmacists usually investigate handwriting, signature and name stamp of prescribers to verify prescriptions in Iran. Anecdotal reports of variations in handwriting and name stamp of physicians who wrote antineoplastic prescriptions raised concerns in this regard. The aim of the study was to investigate the reported diversity and evaluate the quality of writing physician identity and required items in antineoplastic prescriptions.
Methods: All insured hand-written prescriptions contained at least one antineoplastic medication and were dispensed by four main authorized community pharmacies dispensing antineoplastic medications in Tehran during one month were included. Prescriptions that were written by specialties other than oncology-related fields were excluded. Prescriptions of each physician were evaluated considering handwriting and name stamp by experienced pharmacy staff and the frequency of detected handwriting and name stamp types was recorded.
Results: Of the 11022 included prescriptions, 10944 were eligible and written by 241 physicians. Median (third quartile) number of physicians’ prescriptions was 17 (51). Maximum number of observed handwriting and name stamp types were eight and six respectively. High prescribers tended to have several handwriting and name stamp types.
Conclusion: The observed diversity and variation in handwriting and name stamp of the physicians in antineoplastic prescriptions may facilitate the entrance of forged prescription and makes fraud detection difficult. Administrative and regulatory interventions in addition to notification of health care professionals about the observed potential might be necessary.
Basukala S, Mehrotra S. Reducing medication error: A retrospective audit of drug prescriptions in a tertiary care hospital. Int. J. of Analytical, Pharmaceutical and Biomedical Sciences 2015;4(8):26-32.
World Health Organization. Dispensing drugs to patients. Management of drugs at health centre level: training manual 2004.
De Vries T, Henning RH, Hogerzeil H, Fresle D. Guide to good prescribing. Geneva: World Health Organization. 1994;134.
Fontasa-Rosa JC, Paula FJd, Motta MVd, Muñoz DR, Silva Md. Medical rubber stamp: a legal necessity or an informal imposition? Rev Assoc Med Bras 2011;57(1):16-9.
Kaye T. Wayward Prescriptions: Costs of Fraud in Payor Plans. Am Health Drug Benefits 2008;1(6):9.
What Should I Do About a Forged Prescription? : Medscape; Feb 22, 2016; Available from: URL: http://www.medscape.com/viewarticle/858971.
Joudaki H, Rashidian A, Minaei-Bidgoli B, Mahmoodi M, Geraili B, Nasiri M, et al. Improving fraud and abuse detection in general physician claims: a data mining study. Int J Health Policy Manag 2016;5(3):165.
Aral KD, Güvenir HA, Sabuncuoğlu İ, Akar AR. A prescription fraud detection model. Comput Methods Programs Biomed. 2012;106(1):37-46.
Liu Q, Vasarhelyi M, editors. Healthcare fraud detection: A survey and a clustering model incorporating Geo-location information. 29th world continuous auditing and reporting symposium; 2013.
Ahmadi M, Samadbeik M, Sadoughi F. Modeling of outpatient prescribing process in iran: a gateway toward electronic prescribing system. Iran J Pharm Res 2014;13(2):725.
Porterfield A, Engelbert K. Electronic prescribing: improving the efficiency and accuracy of prescribing in the ambulatory care setting. Perspectives in Health Information Management. 2014:1.
Samadbeik M, Ahmadi M. Electronic prescription system: concepts and standards. Health information managment 2013;10(2):312-24.
Files | ||
Issue | Vol 4, No 3-4 (Winter 2016) | |
Section | Brief Report | |
Keywords | ||
Antineoplastic Agents Prescriptions Handwriting Physicians * |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |